
zzso zzso zzso is an zzso drug approved for the treatment of clinically isolated syndrome zzso and zzso multiple sclerosis zzso As an zzso therapy, zzso zzso zzso zzso in treated patients and zzso zzso zzso do not neutralize therapeutic effects on relapses and zzso Rather, it has been suggested that zzso zzso may be associated with improved clinical zzso We evaluated zzso responses in eight patients with zzso treated with zzso for 15 months and zzso responses in zzso zzso mice before and after induction of experimental zzso zzso zzso There were no significant differences from zzso levels of total zzso or zzso zzso in patients with zzso Total zzso zzso and zzso zzso were significantly increased at 15 months of zzso zzso zzso type and zzso were not associated with clinical zzso zzso expanded disability status scale zzso score, disease burden on magnetic resonance images zzso or clinical zzso In contrast, mice with zzso showed a marked increase in zzso zzso and zzso zzso zzso zzso zzso mice demonstrated improved clinical symptoms and lower mortality than zzso zzso Our results suggest that zzso responses to zzso are zzso among patients with zzso with no apparent association between zzso response and clinical zzso Clinical improvements in zzso zzso mice suggest that zzso zzso and zzso may contribute to zzso treatment effects in zzso 

